{Reference Type}: Case Reports
{Title}: Successful treatment of classic pyoderma gangrenosum with intralesional infliximab injection: A case report.
{Author}: Ahmadi K;Aflaki E;Akbarzade Jahromi M;Dastgheib L;
{Journal}: Australas J Dermatol
{Volume}: 64
{Issue}: 3
{Year}: 2023 Aug 16
{Factor}: 2.481
{DOI}: 10.1111/ajd.14072
{Abstract}: Pyoderma gangrenosum (PG) is a rare dermatological disease characterized by the rapid development of painful skin ulcers. While systemic infliximab is considered a standard treatment for patients with PG, herein, we report our success with the use of intralesional infliximab in a 40-year-old woman with systemic lupus erythematosus (SLE) and PG.